La biotecnología española, organismos públicos y empresas, ha invertido 2.040 millones de euros en 20019, un 14% más que en 2018
Read moreHiris y Farmaindustria presentan el libro ‘Innovación sanitaria para salir reforzados de la crisis de la Covid-19’, en el que participan expertos en economía, gestión sanitaria, medicina e inve...
Read moreGracias a la financiación de 591.132€ de la Fundación Unoentrecienmil, España entra a formar parte del consorcio ALL Together para realizar un ensayo clínico pionero en España.
Read moreAura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...
Read moreSe cumplen tres años del nacimiento del Consorcio de Investigación y Medicina Traslacional en Oncología (SCITRON), fruto de la colaboración de Novartis Oncology, el Vall d’Hebron Instituto de On...
Read moreThe activity "Knowing the brain in health and disease: addictions and doping", whose objective has been to present addiction from a multidisciplinary approach, has been widely appreciated by its at...
Read moreThe GenMoz project, funded by the BMGF, will set up a malaria molecular surveillance system to generate data for decision-making
Read moreLAVA Therapeutics B.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced the pricing of i...
Read more El 23 de abril de 2019 se firmó un convenio entre el entonces Ministerio de Ciencia, Innovación y Universidades y el Centro Nacional de Investigaciones Cardiovasculares Carlos III para amplia...
Read more Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Vivet Therapeutics (“Vivet”) announced today an agreement whereby Mirum has the exclusive option to develop and subsequently commercialize Viv...
Read moreThe European Commission has launched a call, COVID19 – HERA Incubator (HORIZON-HLTH-2021-CORONA-01), that will mobilize all means and resources necessary to prevent, mitigate and respond to the p...
Read moreSynendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, today annou...
Read more